GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in healthcare studies, largely due to its impressive impact on treating conditions such as adult-onset diabetes and weight gain. New studies have revealed that in addition to glucose management, GLP-1 medications offer potential for heart well-being